pharma · Osteoarthritis, Knee · Eosinophilic esophagitis · EPRX
EUPRAXIA PHARMACEUTICALS
EUPRAXIA PHARMACEUTICALS INC.
EUPRAXIA PHARMACEUTICALS clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Victoria, CA
- Founded
- 2012
- Employees
- 52
- Programs
- 4
- Drugs
- 1
- Patents
- 3
EUPRAXIA PHARMACEUTICALS projects
4 ClinicalTrials.gov programs sponsored by EUPRAXIA PHARMACEUTICALS.
EUPRAXIA PHARMACEUTICALS has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
EP-104GI
EUPRAXIA PHARMACEUTICALS INC.
Eosinophilic Esophagitis
1 trial -
EP-104IAR 25 mg
EUPRAXIA PHARMACEUTICALS INC.
Osteoarthritis, Knee
1 trial -
TETRACOSACTIDE , EP-104GI
EUPRAXIA PHARMACEUTICALS INC.
Eosinophilic esophagitis
1 trial -
EP-104IAR
EUPRAXIA PHARMACEUTICALS INC.
Osteoarthritis, Knee
1 trial
Frequently asked questions
How many clinical projects does EUPRAXIA PHARMACEUTICALS have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.